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Збірка наукових праць присвячена 210-річчю Харківського національного ме­
дичного університету. У ній представлені матеріали науково-практичної кон­
ференції з міжнародною участю «Гофунговскі читання» у рамках святкування 
210-річчя ХНМУ та міжнародного Дня стоматолога (10.02.2015 р.). Збірка 
включає останні результати наукових досліджень по актуальних проблемах 
стоматології та щелепно-лицьової хірургії з різних країн. У випуск включені 
праці фахівців, які виконані на кафедрах стоматологічного профілю та суміж­
них дисциплін медичних ВНЗ і установ пі слядипломної освіти лікарів, а також 
в практичній охороні здоров'я. У них відбиті експериментальні, теоретичні і 
клінічні питання сучасної стоматології та щелепно-лицьової хірургії. Представ­
лені роботи з питань профілактики, діагности, лікуванню і реабілітації стомато­
логічних захворювань у дорослих і дітей; педагогіки, історії стоматології, ме­
дичного краєзнавства та огляди літератури.
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Conclusions. With reference to the foregoing it is possible to draw a conclusion 
that CGP as well as conjoint course of CGP and lichen acuminatus are accompanied 
by significant changes of local immunity of the oral cavity which become apparent in 
the form of sharp decrease of lysozyme and beta-lysins activity, reduction of the 
amount of C3 components of complement and increase SIgA level in the oral fluid.
Efficiency of our method of treatment of patients with CGP associated with li­
chen acuminatus is proved through recovery of indices of local non-specific immuni­
ty of the oral cavity such as lysozyme and beta-lysins activity and concentration of 
C3 fragments of complement as well as normalization of SIgA level directly after the 
course is finished and in 3 months after treatment.
Normalization of indices of local immunity of the oral cavity is accompanied 
by absence of symptoms of inflammation of parodontium tissue.
Kuzenko Y., Politun A., Lyndin M.
IMMUNOHISTOCHEMICAL STUDY OF P53 AND KI-67 EXPRESSION IN 
GINGIVAL
Department ofpathology, medical institute o f  Sumy state university, Sumy Ukraine
Background. It has long been postulated an association between periodontitis 
and atherosclerosis and it’s outcomes.
Objectives. The objective of this study was to analyze the expression of Ki-67 
and p53 in gingival epithelium.
Material and Methods. 29 pieces of periodontal tissues of patients who had 
died in Sumy Regional Hospital were evaluated for revealing Ki-67 and p53 by im- 
munohistochemistry.
Results. Patients who had died from complications of atherosclerosis by im- 
munohistochemistry basal cells layer were positive 93.2±1.9% (P 0.05) for Ki-67, 
whereas only 50.72±0.5% of their gingival were positive for p53 (P 0.05) With re­
spect to the immunoexpression of Ki-67 in gingival of not atherosclerotic patients 
they had 39.85±2.77% (P 0.01) of positive cells. In the gingival of not atherosclerot­
ic patients presence of p53 was positive 2.07±0.6% (P<0.05)
Conclusions. Proliferative gene Ki-67 expression among patients with not ath­
erosclerotic conditions was low. Patients, who had died from complications of athero­
sclerosis with cellular hyperplasia, since it is merely an adaptive process, indicated an 
increased Ki-67 Gene and p53 expression. Among patients with atherosclerosis it is 
linked to cell’s arrests in the G1 phase of the cell cycle and that provides time for re­
pair of the damaged DNA before entry into S or induction of apoptosis.
Introduction. Antigen Ki - 67 is the prototypic cell cycle-related nuclear pro­
tein, expressed in proliferating cells in all phases of the active cell cycle 
(G l^S ^G 2 ^M p h ase) and reaches its peak in the G2 and Mphases. It rapidly de­
grades after mitosis with a half life of detectable antigen being an hour or less. It is 
absent in resting (GO) cells. Antibodies of Ki - 67 are useful in the cell growing frac­
tion in neoplasms [1] Antigen Ki-67 expression also appears when DNA synthesis is 
stopped or when the cell undergoes apoptosis. However, according to other investiga­
tors, the markers of proliferation that are in use recently, such as Ki-67, can only
288
yield a limited picture of its involvement in the cell cycle [2]. Increase in Ki-67 ex­
pression was recently demonstrated in the gingival epithelial cells and fibroblasts of 
the lamina propria of patients with gingival overgrowth induced by nifedipine, pheny­
toin or cyclosporin A [3, 4]. Nevertheless, Ki-67 can be used to measure the growth 
fraction, both in normal, premalignant, and malignant tissues. [5] Some are also of 
the opinion that Ki-67 as tumor growth stimulating genes marker and p53 as tumor 
suppressor gene marker are closely associated with their prognostic value. Saito et al. 
found p53 expression in isolated cells of the suprabasal layer of the gingival epitheli­
um in seven out of 11 patients with nifedipine-induced gingival enlargement [3].
Immunohistochemical markers, such as p53, and Ki-67, can be used in paraffin 
sections to show the presence of proliferative genes or cellular proliferation capacity 
and possible early malignant changes [6]. The study shows such an expression of 
p53, and Ki-67 in proliferative genes under the influence of atherosclerosis.
Methods. The study samples consisted of periodontal tissues of patients who died 
in Sumy Regional Hospital Patients and were investigated for p53 and Ki-67 antibodies. 
The subjects were divided into two equal groups: Patient’s Group (Group I): included 20 
people who had died from complications of atherosclerosis. Control Group (Group II): in­
cluded 9 patients with various diagnoses (not atherosclerotic ones)
Ethics statement. All study and family the deceased participants were in­
formed about the study and those who agreed to participate signed a consent form. 
Ethical approval for conducting the study was obtained from the Health Ministry of 
Ukraine (HMU). Approval for performing oral examination was obtained from the 
authorities of the respective hospital and clinic. Information about the biopsy made in 
medical records and postmortem epicrisis Patients who agreed to take part on a sur­
veillance confidential study, in accordance to the Local Research Ethics committee 
from medical institute of Sumy State University, Sumy Ukraine, approved under the 
number 013U003315, were enrolled in this study.
Paraffin sections were prepared for acridine orange staining by mounting on 
the slides, drying on a hot plate, and then sections were immersed into three sets of 
xylene for 2 minutes each followed by three sets of absolute ethanol for 5 minutes 
and finally rinsed with tap water. The aim was to remove the wax and dehydrate the 
sections. Slides (paraffin) were placed into acridine orange staining solution for 15 
minutes, and rinsed with phosphate-buffered saline (PBS). Then the slide was soaked 
in 0.1% calcium chloride solution for 3 minutes and was washed with PBS once 
again. Cover glass was mounted for observation under a fluorescent microscope to 
observe and read the result.
Immunostaining for p53 and Ki-67 was performed on formalin-fixed (pH 7,4 ), 
paraffin-embedded thyroid tissue sections using mouse monoclonal antigenes - p53 and 
Ki-67 (Thermo Fisher Scientific UK). Briefly, 4pm thick tissue sections were dewaxed 
in xylene and were brought to water through graded alcohols. Antigen retrieval was per­
formed by microwaving slides in IQmM citrate buffer (pH 6.2) for 30 min at high power, 
according to the manufacturer’s instructions. To remove the endogenous peroxidase ac­
tivity, sections were then treated with freshly prepared 1.0% hydrogen peroxide in the 
dark environment for 30 min at temperature 37° C. Non-specific antibody binding was 
blocked by dint of blocking serum. The sections were incubated at temperature 37° C for
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30 minutes, with primary antibodies against p53 and Ki-67 diluted with ratio 1:100 in 
phosphate buffered saline (PBS) pH 7.2, after 3 washings with PBS. Anti-(mouse IgG)- 
horseradish peroxidase conjugate ( 1:40 000 dilution) was used for the detection of the 
p53 and Ki-67 primary antibodies, sections were then incubated for 20 min, at tempera­
ture 37° C. The color was developed by DAB.
Appearance of positive factors was detected semi-quantitatively by counting 
positive cells in visual field (p53, and Ki-67 -  0-5% - few, 5-20% - moderate, 20­
40% - numerous, 40-100% - abundance of positive structures in visual field)
Data were analyzed using the program Origin Version 8. The Student method 
was used to perform simple comparative analysis. The variables were regarded as 
normally distributed.
Results. In Group 1 p53 and Ki-67 were expressed in all specimens. Expression 
of Ki-67 in gingiva is shown in figures 1 and 2. The immunoexpression of these pro­
teins was confirmed by the presence of brown stained nucleus in gingival. Ki-67 was
Fig l Expression o f  Ki-67 in gingiva, group I  
( x300 magnification) A -  Expression o f  Ki- 
67 in basal cell o f  epithelium B - without 
Ki-67 expression in nucleus C -  apoptosis
Fig 2 Expression o f  Ki-67 in gingiva, group I  
( x l0 0  magnification) A - mixed cellular infil­
tration B - proliferating epithelial cord with 
the Ki-67 expression
expressed in gingival and stromal cells at the invasion front in all. In general, Ki-67 
staining was more intense in the basal cells gingiva than in the stroma. By immuno- 
histochemistry basal cells layer, 93.2±1.9% (/><0.05) of gingiva were positive for Ki- 
67 (Fig 1A), whereas only 50.72±0.5% of gingival were positive for p53 (/><0.05) 
(Fig 4A). In Figure 1, Ki-67 was expressed with apoptosis calves (Figl C) of a score 
of 2 in cases of atherosclerosis. In Figure 2 we can see the direction epithelial prolif­
eration (Fig2 B) into inflammatory (Fig2 A)
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A B
Fig 3 Expression ofK i-67 in gingiva, group II 
( x 400magnification) A - cell with Ki-67 expression 
in nucleus B - cell without Ki-67 expression in nu­
cleus
With respect to the immuno- 
expression ofKi-67 in gingival group 
II, were detected 39.85±2.77% 
(JP<0.01) of positive cells (Fig 3). In 
the gingiva immunoexpression of p53 
was classified with a score of 9 in 
most cases 2.07±0.6% (JP<0.05) (Fig
5). W
Induction of the enzymatic 
activity of Ki-67 was increased by 
p53. This could be explained by the 
fact that Ki-67 is physiologically 
expressed by the gingival and p53 
expression is weak or absent in gin­
gival and induced apoptosis in the 
granular layer of the epithelium.
Discussion. A study by Varga 
and Tyldesley, [7] have shown that squamous cell carcinoma may arise in gingival 
hyperplasia induced by cyclosporine. In the present group I of patients, the density of 
Ki-67-positive cells per mm2 was significantly higher than among the patients of 
group II. Flowever the p53 protein is arresting cells in the G1 phase of the cell cycle 
and allows time for repair of the damaged DNA before entry into S phase [8]. In 
normal tissues without impaired DNA, the half-life of protein p53 is too short to per­
mit immunohistochemical detection. Nevertheless, antigen-retrieval techniques have
nr \ i i
A A B C
Fig 4 Expression o f  p53 in gingiva, group 
I  ( x 40magnification) A -  apoptosis
calves with p53expression and remnants 
o f  the cell nucleus B -  apoptosis calves 
without p53expression and cell nucleus C 
-  cells without p53expression
Fig 5 Expression o f  p53 in gingiva, group 
magnification) II A -  cells without p53expression in the 
basal layer, B - cells without p53expression prickle 
layer, C cells without p53expression a granular layer.
resulted in the increased detection of p53 protein in normal tissues and it is possible
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to immunohistochemically detect some p53-positive cells. This same effect is shown 
on patient’s gingival in the group I. Our study supports the Ki-67 protein expression 
as an absolute requirement for progressive growth of cell division [9].
Conclusions. Proliferative gene Ki-67 expression among patients with not ath­
erosclerotic conditions was low. Patients, who had died from complications of athero­
sclerosis with cellular hyperplasia, since it is merely an adaptive process, indicated an 
increased Ki-67 Gene and p53 expression. Among patients with atherosclerosis it is 
linked to cell’s arrests in the G1 phase of the cell cycle and that provides time for re­
pair of the damaged DNA before entry into S or induction of apoptosis.
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Ryabokon, E. N., Khudiakova, M. B.
CORRECTION OF CYTOKINE MISBALANCE IN PATIENTS WITH 
CHRONIC GENERALIZED PERIODONTITIS OF INITIAL-I DEGREES OF 
SEVERITY BY MEANS OF LOCAL APPLICATION OF QUERCETINUM 
GRANULES AND LIPOSOMAL QUERCETINUM-LECITHIN COMPLEX
Kharkiv National Medical University, Kharkiv, Ukraine
Introduction. Efficiency of local application of medical drugs in periodontal 
tissues depends on the display of substances in the periodontal pocket (PP), choice of 
medical substances, method of his application, contact with the gingival oral mucosa 
and maintainance of this concentration. Therefore it is necessary advantage to give to 
the forms and pathways of medications with the controlled and long action [5, 6]. 
Development and application high-efficiency and safe facilities of drug therapy of 
chronic generalized periodontitis (HGP) the last years legally considered one of prior­
ity directions of native and foreign researchers [1, 2, 3]. Medical local therapy is inal­
ienable part of complex treatment of HGP [4].
Liposomes, owing to their small size, penetrate regions that may be inaccessi­
ble to other delivery systems. It is noteworthy that only liposomes have been largely 
exploited for drug delivery because the methods of preparation are generally simple 
and easy to scale-up. The aim of using liposomal carriers is generally, to increase the 
specificity towards cells or tissues, to improve the bioavailability of drugs by increas­
ing their diffusion through biological membranes, to protect them against enzyme in-
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